Partnership Aims to Bring Novel Gastroenterology Therapies to Worldwide Market
May 20th 2019Parvus Therapeutics and Genentech have entered into a worldwide collaboration and licensing agreement for the development, manufacturing, and commercialization of treatments for inflammatory bowel disease, autoimmune liver diseases, and celiac disease using nanomedicines (Navacim) developed by Parvus.
Read More
Debate Continues Over Co-pay Accumulator Programs
May 18th 2019Bruce Feinberg, DO, vice president and chief medical officer of Cardinal Health Specialty Solutions, recently explored both sides of the debate as to whether these tools are effective for managing costs or add barriers to patient access.
Read More
FDA OKs Expanded Indication for Short Bowel Syndrome Treatment to Include Children
May 17th 2019Officials with the FDA have approved extending the indication of Takeda Pharmaceuticals’ teduglutide (Gattex) for injection to pediatric patients age 1 year and older with Short Bowel Syndrome who need additional nutrition or fluids from intravenous feeding.
Read More
NHIA 2019: Empowering Pharmacies to Grow in Specialty
May 17th 2019The convenience of home infusion for these products is very enticing for patients who require them and positioning home infusion pharmacies as partners with prescribers and patients is critical to help support this influx of new therapies.
Read More
CMS Action Aims to Lower Prescription Drug Prices, Increase Cost Transparency
May 17th 2019The final rule requires Part D plans to adopt tools that provide clinicians with information that they can discuss with patients on out-of-pocket costs for prescription drugs at the time a prescription is written.
Read More
Pharmacy Times Demonstrates Pharmacy Industry Leadership in 2019 KANTAR Readership Study
May 16th 2019The annual KANTAR Readership Study encompasses readership habits of thousands of pharmacists and pharmacy professionals, working in the areas of chain, independent retail pharmacies and health-system pharmacies.
Read More
Point-of-Sale Solution Aims to Deliver Accurate Drug Discount Compliance
May 15th 2019This first-to-market point-of-sale platform combines industry expertise, artificial intelligence and comprehensive, deep-data libraries to seek out and identify errors so that the right discounts are applied to the right transaction.
Read More